Septerna (SEPN) Financials

Septerna logo
$41.67 -0.93 (-2.18%)
Closing price 04:00 PM Eastern
Extended Trading
$41.64 -0.02 (-0.06%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Septerna

Annual Income Statements for Septerna

This table shows Septerna's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
4.75 -72 -49
Consolidated Net Income / (Loss)
4.18 -72 -49
Net Income / (Loss) Continuing Operations
4.19 -72 -49
Total Pre-Tax Income
4.87 -72 -49
Total Operating Income
2.08 -81 -68
Total Gross Profit
0.15 1.08 46
Total Revenue
0.15 1.08 46
Operating Revenue
0.15 1.08 46
Total Cost of Revenue
0.00 0.00 0.00
Total Operating Expenses
-1.92 82 114
Selling, General & Admin Expense
9.72 17 29
Research & Development Expense
36 65 98
Other Special Charges / (Income)
-48 0.00 -13
Total Other Income / (Expense), net
2.79 8.53 19
Interest & Investment Income
2.79 8.62 20
Other Income / (Expense), net
- -0.09 -0.10
Income Tax Expense
0.69 -0.50 0.01
Basic Earnings per Share
$0.29 ($7.26) ($1.10)
Weighted Average Basic Shares Outstanding
1.93M 9.89M 44.26M
Diluted Earnings per Share
$0.29 ($7.26) ($1.10)
Weighted Average Diluted Shares Outstanding
2.18M 9.89M 44.26M
Weighted Average Basic & Diluted Shares Outstanding
- 44.44M 44.91M

Quarterly Income Statements for Septerna

This table shows Septerna's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - 19 - - - 46
Net Income / (Loss) Attributable to Common Shareholders
-14 -16 -20 -21 -21 -25 8.17 -11 -8.64 -13 -27
Consolidated Net Income / (Loss)
-14 -16 -21 -21 -21 -25 8.17 -11 -8.64 -13 -27
Net Income / (Loss) Continuing Operations
-14 -17 -21 -20 -21 -25 8.17 -11 -8.64 -13 -27
Total Pre-Tax Income
-14 -17 -21 -21 -21 -25 8.17 -11 -8.30 -12 -22
Total Operating Income
-15 -18 -23 -25 -26 -29 2.61 -16 -13 -17 -27
Total Gross Profit
0.32 0.37 0.18 0.21 0.22 0.12 21 24 27 27 19
Total Revenue
0.32 0.37 0.18 0.21 0.22 0.12 21 24 27 27 19
Operating Revenue
0.32 0.37 0.18 0.21 0.22 0.12 21 24 27 27 19
Total Cost of Revenue
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Operating Expenses
16 18 23 25 26 29 19 40 40 44 46
Selling, General & Admin Expense
2.65 3.40 4.89 5.61 6.86 6.91 7.12 8.28 10 8.45 9.55
Research & Development Expense
13 15 18 19 19 22 24 32 30 35 37
Other Special Charges / (Income)
- - 0.00 - - - -13 - - - 0.00
Total Other Income / (Expense), net
1.23 1.52 1.89 3.89 4.43 4.14 5.56 5.30 5.00 4.78 5.26
Interest & Investment Income
1.28 1.53 1.90 3.91 4.46 4.17 5.57 5.34 5.03 4.80 5.27
Other Income / (Expense), net
-0.05 -0.02 -0.01 -0.02 -0.03 -0.03 -0.01 -0.04 -0.03 -0.02 -0.01
Income Tax Expense
0.09 0.11 -0.14 -0.56 0.00 0.00 0.00 0.01 0.34 0.97 4.62
Basic Earnings per Share
($6.35) ($7.03) ($8.40) $14.52 ($0.49) ($0.56) $0.18 ($0.23) ($0.19) ($0.29) ($0.57)
Weighted Average Basic Shares Outstanding
2.23M 2.34M 2.44M 9.89M 43.94M 44.17M 44.34M 44.26M 44.76M 45.04M 46.91M
Diluted Earnings per Share
($6.35) ($7.03) ($8.40) $14.52 ($0.49) ($0.56) $0.18 ($0.23) ($0.19) ($0.29) ($0.57)
Weighted Average Diluted Shares Outstanding
2.23M 2.34M 2.44M 9.89M 43.94M 44.17M 45.60M 44.26M 44.76M 45.04M 46.91M
Weighted Average Basic & Diluted Shares Outstanding
- - 44.40M 44.44M 44.56M 44.59M 44.77M 44.91M 45.08M 46.68M 47.55M

Annual Cash Flow Statements for Septerna

This table details how cash moves in and out of Septerna's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
58 150 -117
Net Cash From Operating Activities
-39 -67 110
Net Cash From Continuing Operating Activities
-39 -67 123
Net Income / (Loss) Continuing Operations
4.18 -72 -49
Consolidated Net Income / (Loss)
4.18 -72 -49
Depreciation Expense
0.85 1.40 1.60
Amortization Expense
0.00 -1.41 -3.45
Non-Cash Adjustments To Reconcile Net Income
-46 5.03 11
Changes in Operating Assets and Liabilities, net
2.19 -0.69 163
Net Cash From Investing Activities
22 -161 -229
Net Cash From Continuing Investing Activities
22 -161 -242
Purchase of Property, Plant & Equipment
-2.88 -2.10 -0.52
Purchase of Investments
0.00 -213 -451
Sale and/or Maturity of Investments
0.00 32 210
Net Cash From Financing Activities
75 378 1.69
Net Cash From Continuing Financing Activities
75 378 1.69
Issuance of Preferred Equity
75 75 0.00
Issuance of Common Equity
0.00 303 0.72
Other Financing Activities, net
0.00 0.05 0.97
Cash Income Taxes Paid
0.08 0.23 0.00

Quarterly Cash Flow Statements for Septerna

This table details how cash moves in and out of Septerna's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-7.14 50 -43 150 -28 -21 131 -199 -49 13 82
Net Cash From Operating Activities
-17 -13 -17 -21 -23 -20 169 -15 -26 -22 -14
Net Cash From Continuing Operating Activities
-17 -13 -17 -21 -23 -20 169 -2.49 -26 -22 -14
Net Income / (Loss) Continuing Operations
-14 -16 -21 -21 -21 -25 8.17 -11 -8.64 -13 -27
Consolidated Net Income / (Loss)
-14 -16 -21 -21 -21 -25 8.17 -11 -8.64 -13 -27
Depreciation Expense
0.32 0.33 0.36 0.39 0.40 0.41 0.40 0.40 0.42 0.43 0.39
Amortization Expense
-0.07 -0.16 -0.37 -0.81 -0.97 -0.98 -0.62 -0.89 -0.76 -0.46 -0.60
Non-Cash Adjustments To Reconcile Net Income
0.69 0.71 1.63 2.00 1.99 2.79 -11 17 6.05 6.18 4.86
Changes in Operating Assets and Liabilities, net
-3.48 2.57 2.09 -1.87 -3.29 2.33 172 -8.36 -23 -15 8.16
Net Cash From Investing Activities
9.57 -12 -25 -133 -4.87 -0.79 -38 -185 -24 18 33
Net Cash From Continuing Investing Activities
9.57 -12 -25 -133 -4.87 -0.79 -38 -198 -24 18 33
Purchase of Property, Plant & Equipment
-0.76 -0.15 -0.58 -0.61 -0.38 -0.06 -0.01 -0.07 -0.83 - -0.13
Purchase of Investments
-12 -20 -34 -148 -50 -64 -110 -227 -105 -48 -45
Sale and/or Maturity of Investments
0.00 7.91 9.43 15 45 63 59 42 82 66 78
Net Cash From Financing Activities
0.00 75 -1.32 304 0.07 0.34 0.26 1.02 0.33 17 63
Net Cash From Continuing Financing Activities
0.00 75 -1.32 304 0.07 0.34 0.26 1.02 0.33 17 63
Issuance of Common Equity
- - - - - - - - - - 61
Other Financing Activities, net
0.00 -0.05 -1.26 1.36 0.07 0.34 0.26 0.30 0.33 2.08 1.74

Annual Balance Sheets for Septerna

This table presents Septerna's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
131 457 596
Total Current Assets
113 357 411
Cash & Equivalents
88 238 121
Short-Term Investments
0.00 113 270
Accounts Receivable
23 0.17 10
Prepaid Expenses
1.42 5.73 9.52
Plant, Property, & Equipment, net
4.67 5.09 4.43
Total Noncurrent Assets
14 95 181
Long-Term Investments
0.00 70 158
Other Noncurrent Operating Assets
14 25 23
Total Liabilities & Shareholders' Equity
131 457 596
Total Liabilities
20 37 214
Total Current Liabilities
6.91 13 87
Accounts Payable
2.64 3.20 10
Accrued Expenses
4.28 7.80 12
Current Deferred Revenue
- 0.00 62
Other Current Liabilities
0.00 1.85 2.21
Total Noncurrent Liabilities
13 24 127
Noncurrent Deferred Revenue
- 0.00 106
Other Noncurrent Operating Liabilities
13 24 21
Commitments & Contingencies
0.00 0.00 0.00
Redeemable Noncontrolling Interest
149 0.00 0.00
Total Equity & Noncontrolling Interests
-38 420 382
Total Preferred & Common Equity
-38 420 382
Preferred Stock
0.00 0.00 0.00
Total Common Equity
-38 420 382
Common Stock
8.20 538 549
Retained Earnings
-47 -118 -167
Accumulated Other Comprehensive Income / (Loss)
0.00 0.06 0.62

Quarterly Balance Sheets for Septerna

This table presents Septerna's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
174 434 415 607 570 567 619
Total Current Assets
133 342 334 492 368 396 507
Cash & Equivalents
88 210 189 320 72 85 167
Short-Term Investments
42 126 137 154 276 288 311
Accounts Receivable
0.21 0.25 0.15 8.65 11 12 19
Prepaid Expenses
2.67 6.21 7.43 8.69 9.82 12 9.86
Plant, Property, & Equipment, net
5.41 5.04 4.69 4.32 4.33 3.90 3.83
Total Noncurrent Assets
35 87 76 111 197 167 108
Long-Term Investments
6.98 62 53 87 175 144 87
Other Noncurrent Operating Assets
28 24 24 23 23 22 22
Total Liabilities & Shareholders' Equity
174 434 415 607 570 567 619
Total Liabilities
38 34 38 218 191 180 191
Total Current Liabilities
13 11 15 75 78 79 105
Accounts Payable
6.13 4.35 6.54 3.73 7.46 3.97 6.96
Accrued Expenses
5.99 4.35 6.56 7.83 8.63 13 19
Current Deferred Revenue
- - - 62 60 60 76
Other Current Liabilities
1.12 1.94 2.03 2.12 2.31 2.41 2.51
Total Noncurrent Liabilities
24 23 23 143 113 101 87
Noncurrent Deferred Revenue
- - - 121 92 80 66
Other Noncurrent Operating Liabilities
24 23 23 22 21 21 21
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
224 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-87 400 378 389 378 387 428
Total Preferred & Common Equity
-87 400 378 389 378 387 428
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-87 400 378 389 378 387 428
Common Stock
10 540 542 545 555 577 645
Retained Earnings
-98 -140 -165 -157 -176 -189 -216
Accumulated Other Comprehensive Income / (Loss)
0.18 0.20 0.18 0.38 -0.57 -1.26 -2.05

Annual Metrics And Ratios for Septerna

This table displays calculated financial ratios and metrics derived from Septerna's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 - 44,774,192.00
DEI Adjusted Shares Outstanding
0.00 - 44,774,192.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 - -1.09
Growth Metrics
- - -
Profitability Metrics
- - -
Net Operating Profit after Tax (NOPAT)
1.78 -57 -48
Return On Investment Capital (ROIC_SIMPLE)
-4.64% -13.47% -12.52%
Earnings before Interest and Taxes (EBIT)
2.08 -81 -68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2.92 -81 -70
Valuation Ratios
- - -
Leverage & Solvency
- - -
Liquidity Ratios
- - -
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -33 118
Efficiency Ratios
- - -
Capital & Investment Metrics
- - -
Invested Capital
22 -0.74 -167
Increase / (Decrease) in Invested Capital
0.00 -23 -166
Book Value per Share
($19.90) $9.46 $8.53
Tangible Book Value per Share
($19.90) $9.46 $8.53
Total Capital
111 420 382
Total Debt
0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
-88 -421 -549
Capital Expenditures (CapEx)
2.88 2.10 0.52
Debt-free, Cash-free Net Working Capital (DFCFNWC)
17 -6.95 -67
Debt-free Net Working Capital (DFNWC)
106 344 324
Net Working Capital (NWC)
106 344 324
Net Nonoperating Expense (NNE)
-2.40 15 1.07
Net Nonoperating Obligations (NNO)
-88 -421 -549
Total Depreciation and Amortization (D&A)
0.85 -0.01 -1.84
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 ($7.26) ($1.10)
Adjusted Weighted Average Basic Shares Outstanding
0.00 9.89M 44.26M
Adjusted Diluted Earnings per Share
$0.00 ($7.26) ($1.10)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 9.89M 44.26M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 44.44M 44.91M
Normalized Net Operating Profit after Tax (NOPAT)
-39 -57 -57
Debt Service Ratios
- - -
Payout Ratios
- - -

Quarterly Metrics And Ratios for Septerna

This table displays calculated financial ratios and metrics derived from Septerna's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
0.00 0.00 0.00 44,402,742.00 44,442,496.00 44,558,338.00 44,585,135.00 44,774,192.00 44,906,374.00 45,075,533.00 46,676,947.00
DEI Adjusted Shares Outstanding
0.00 0.00 0.00 44,402,742.00 44,442,496.00 44,558,338.00 44,585,135.00 44,774,192.00 44,906,374.00 45,075,533.00 46,676,947.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 0.00 -0.46 -0.48 -0.56 0.19 -0.25 -0.19 -0.29 -0.57
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 433.33% - -30.91% -67.84% 12,113.07% - 12,010.96% 22,375.63% -12.16%
EBITDA Growth
0.00% 0.00% -87.41% - -73.31% -65.17% 110.58% - 48.45% 42.87% -1,249.25%
EBIT Growth
0.00% 0.00% -87.35% - -66.93% -60.41% 111.56% - 48.60% 41.87% -1,144.52%
NOPAT Growth
0.00% 0.00% -87.29% - -67.27% -60.41% 116.56% - 48.67% 41.90% -829.16%
Net Income Growth
0.00% 0.00% -87.51% - -51.60% -51.07% 139.82% - 59.78% 47.52% -425.34%
EPS Growth
0.00% 0.00% -54.13% - 92.28% 92.03% 102.14% - 61.22% 48.21% -416.67%
Operating Cash Flow Growth
0.00% 0.00% 0.00% - -39.69% -56.21% 1,103.97% - -9.81% -9.33% -108.16%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% - 0.00% 0.00% 1,262.81% - 776.44% 724.05% -131.27%
Invested Capital Growth
0.00% 0.00% 0.00% - 0.00% 0.00% -22,550.98% - -7,214.12% -7,828.65% 20.58%
Revenue Q/Q Growth
0.00% 16.72% -52.43% - 0.00% -45.66% 17,963.03% - 9.97% 0.84% -29.41%
EBITDA Q/Q Growth
0.00% -17.07% -26.03% - 0.00% -11.57% 108.07% - 17.43% -23.63% -62.45%
EBIT Q/Q Growth
0.00% -16.36% -24.77% - 0.00% -11.82% 108.99% - 17.01% -26.46% -61.58%
NOPAT Q/Q Growth
0.00% -16.62% -24.83% - 0.00% -11.84% 112.89% - 16.99% -26.59% -61.73%
Net Income Q/Q Growth
0.00% -16.06% -24.83% - 0.00% -15.65% 132.91% - 19.57% -50.91% -104.00%
EPS Q/Q Growth
0.00% -10.71% -19.49% - 0.00% -14.29% 132.14% - 17.39% -52.63% -96.55%
Operating Cash Flow Q/Q Growth
-89.96% 22.28% -29.47% - -11.38% 13.09% 932.09% - -71.02% 13.47% 37.92%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% - 0.00% 7.48% 1,036.73% - -11.91% -14.65% -146.94%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% - 0.00% -181.08% -10,457.54% - 13.85% 9.64% -5.75%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
100.00% 100.00% 100.00% - 100.00% 100.00% 100.00% - 100.00% 100.00% 100.00%
EBITDA Margin
-4,824.61% -4,839.19% -12,821.59% - -12,103.20% -24,851.26% 11.11% - -51.52% -63.16% -145.35%
Operating Margin
-4,886.44% -4,882.43% -12,812.50% - -11,831.05% -24,351.26% 12.16% - -50.15% -62.95% -144.21%
EBIT Margin
-4,901.58% -4,886.49% -12,817.61% - -11,843.84% -24,372.27% 12.13% - -50.26% -63.03% -144.28%
Profit (Net Income) Margin
-4,468.77% -4,443.51% -11,660.80% - -9,806.39% -20,872.27% 38.02% - -32.56% -48.73% -140.83%
Tax Burden Percent
99.35% 99.34% 99.34% - 100.00% 100.00% 100.00% - 104.06% 108.07% 121.03%
Interest Burden Percent
91.77% 91.54% 91.58% - 82.80% 85.64% 313.38% - 62.26% 71.54% 80.65%
Effective Tax Rate
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% - -8,015.11% 0.00% 0.00% - 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% - -8,013.43% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% - 7,973.01% 0.00% 0.00% - 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 0.00% 0.00% - -42.10% -23.18% -22.38% - -9.26% -6.34% -14.45%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% - -26.66% -42.61% 0.69% - -7.24% -12.69% -22.66%
Return on Assets (ROA)
0.00% 0.00% 0.00% - -22.07% -36.49% 2.15% - -4.69% -9.81% -22.12%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% - -42.10% -23.18% -12.83% - -9.26% -6.34% -14.45%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% - -19.76% 0.00% 0.00% - 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-11 -13 -16 -17 -18 -20 2.61 -11 -9.31 -12 -19
NOPAT Margin
-3,420.50% -3,417.70% -8,968.75% - -8,281.74% -17,045.88% 12.16% - -35.10% -44.06% -100.95%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% -6.89% - -1.68% -2.40% 1.59% - 0.15% -0.28% -1.34%
Return On Investment Capital (ROIC_SIMPLE)
- - 18.06% -4.12% -4.53% -5.37% 0.67% -2.94% -2.46% -3.05% -4.45%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
SG&A Expenses to Revenue
837.22% 918.92% 2,780.68% - 3,131.51% 5,805.88% 33.11% - 38.79% 31.59% 50.60%
R&D to Revenue
4,149.21% 4,063.51% 10,131.82% - 8,799.54% 18,645.38% 112.88% - 111.36% 131.35% 193.61%
Operating Expenses to Revenue
4,986.44% 4,982.43% 12,912.50% - 11,931.05% 24,451.26% 87.84% - 150.15% 162.95% 244.21%
Earnings before Interest and Taxes (EBIT)
-16 -18 -23 -25 -26 -29 2.61 -16 -13 -17 -27
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-15 -18 -23 -25 -27 -30 2.39 -17 -14 -17 -27
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 - 0.64 1.24 2.21 - 2.84 3.90 4.29
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 - 0.64 1.24 2.21 - 2.84 3.90 4.29
Price to Revenue (P/Rev)
0.00 0.00 0.00 - 260.39 643.01 38.91 - 14.89 15.25 19.07
Price to Earnings (P/E)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 - 0.00 120.71 13.44 - 7.66 10.03 13.20
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 - 0.00 0.00 2.84 - 5.13 9.36 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 5.19 10.16 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Financial Leverage
0.00 0.00 -1.01 - -1.00 -1.00 -1.33 - -1.18 -1.17 -1.38
Leverage Ratio
0.00 0.00 1.27 - 1.08 1.10 1.49 - 1.29 1.28 1.50
Compound Leverage Factor
0.00 0.00 1.17 - 0.90 0.94 4.66 - 0.80 0.92 1.21
Debt to Total Capital
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 163.92% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 0.00% -63.92% - 100.00% 100.00% 100.00% - 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Altman Z-Score
0.00 0.00 0.00 - 4.79 7.57 2.87 - 3.60 5.31 6.06
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% - 0.00% 0.00% 42.66% - 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 0.00 10.08 - 32.19 22.09 6.53 - 4.71 4.99 4.84
Quick Ratio
0.00 0.00 9.88 - 31.61 21.60 6.42 - 4.58 4.85 4.74
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 -15 0.00 -20 -19 175 155 136 116 -55
Operating Cash Flow to CapEx
-2,187.30% -8,716.11% -2,909.00% - -6,110.73% -34,977.59% 1,298,515.38% - -3,080.89% 0.00% -10,840.94%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 - 0.00 0.00 0.06 - 0.14 0.20 0.16
Accounts Receivable Turnover
0.00 0.00 0.00 - 3.91 4.81 4.98 - 13.03 16.06 6.99
Inventory Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 - 0.19 0.15 4.53 - 15.42 23.03 23.64
Accounts Payable Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Sales Outstanding (DSO)
0.00 0.00 0.00 - 93.40 75.92 73.31 - 28.02 22.72 52.19
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 - 93.40 75.92 73.31 - 28.02 22.72 52.19
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 0.00 -0.76 -0.74 2.02 -1.64 -173 -167 -144 -130 -137
Invested Capital Turnover
0.00 0.00 0.00 - 0.97 -0.89 -0.25 - -1.02 -1.50 -0.62
Increase / (Decrease) in Invested Capital
0.00 0.00 -0.76 0.00 2.02 -1.64 -172 -166 -146 -128 36
Enterprise Value (EV)
0.00 0.00 284 - -144 88 296 - 553 992 1,271
Market Capitalization
197 197 197 - 254 467 858 - 1,076 1,508 1,836
Book Value per Share
$0.00 $0.00 ($35.77) $9.46 $9.01 $8.47 $8.72 $8.53 $8.43 $8.58 $9.17
Tangible Book Value per Share
$0.00 $0.00 ($35.77) $9.46 $9.01 $8.47 $8.72 $8.53 $8.43 $8.58 $9.17
Total Capital
0.00 0.00 137 420 400 378 389 382 378 387 428
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 0.00 -138 -421 -398 -379 -562 -549 -522 -517 -565
Capital Expenditures (CapEx)
0.76 0.15 0.58 0.61 0.38 0.06 0.01 0.07 0.83 0.00 0.13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 -10 -6.95 -4.17 -7.55 -58 -67 -58 -55 -76
Debt-free Net Working Capital (DFNWC)
0.00 0.00 120 344 332 319 416 324 290 317 402
Net Working Capital (NWC)
0.00 0.00 120 344 332 319 416 324 290 317 402
Net Nonoperating Expense (NNE)
3.32 3.80 4.74 3.37 3.34 4.55 -5.56 -0.48 -0.67 1.25 7.53
Net Nonoperating Obligations (NNO)
0.00 0.00 -138 -421 -398 -379 -562 -549 -522 -517 -565
Total Depreciation and Amortization (D&A)
0.24 0.18 -0.01 -0.42 -0.57 -0.57 -0.22 -0.49 -0.33 -0.04 -0.20
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% - -427.23% -1,039.53% -262.86% - -79.59% -56.11% -79.07%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% - 33,964.28% 43,941.32% 1,888.86% - 401.21% 320.42% 418.09%
Net Working Capital to Revenue
0.00% 0.00% 0.00% - 33,964.28% 43,941.32% 1,888.86% - 401.21% 320.42% 418.09%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($8.40) $14.52 ($0.49) ($0.56) $0.18 ($0.23) ($0.19) ($0.29) ($0.57)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 2.44M 9.89M 43.94M 44.17M 44.34M 44.26M 44.76M 45.04M 46.91M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($8.40) $14.52 ($0.49) ($0.56) $0.18 ($0.23) ($0.19) ($0.29) ($0.57)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 2.44M 9.89M 43.94M 44.17M 45.60M 44.26M 44.76M 45.04M 46.91M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 44.40M 44.44M 44.56M 44.59M 44.77M 44.91M 45.08M 46.68M 47.55M
Normalized Net Operating Profit after Tax (NOPAT)
-11 -13 -16 -17 -18 -20 -6.92 -11 -9.31 -12 -19
Normalized NOPAT Margin
-3,420.50% -3,417.70% -8,968.75% - -8,281.74% -17,045.88% -32.19% - -35.10% -44.06% -100.95%
Pre Tax Income Margin
-4,498.11% -4,472.97% -11,738.07% - -9,806.39% -20,872.27% 38.02% - -31.29% -45.09% -116.36%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Septerna’s Q2 2026 results show a growing revenue base and substantial liquidity, but the company remains unprofitable and dependent on its cash and investment portfolio to fund research and development. Revenue increased to $26.7 million from $26.5 million in Q1 2026 and $119,000 in Q2 2025. The year-over-year comparison is affected by the restated Q2 2025 figure, but revenue has increased sharply since the first half of 2025.

  • Revenue growth has accelerated: Quarterly revenue rose from $219,000 in Q1 2025 and $119,000 in Q2 2025 to $21.5 million in Q3 2025, $24.1 million in Q4, $26.5 million in Q1 2026 and $26.7 million in Q2 2026.
  • Operating losses improved sequentially: The Q2 2026 operating loss was $16.8 million, compared with a $25.9 million loss in Q1 2025 and a $13.3 million loss in Q1 2026. Revenue growth is beginning to offset some of the company’s expanding cost base.
  • Septerna maintains significant liquidity: At June 30, 2026, the company held $84.7 million of cash, $287.7 million of short-term investments and $144.2 million of long-term investments, totaling approximately $516.5 million in cash and investments.
  • The balance sheet has limited traditional debt exposure: Total liabilities were $180.0 million versus $386.7 million of equity. Much of the liabilities consisted of deferred revenue rather than debt, reducing near-term financing pressure.
  • Liquidity improved during Q2: Cash and equivalents increased by $13.1 million during the quarter to $84.7 million, supported by $65.9 million of investment maturities or sales and $16.8 million of financing cash flow.
  • Research spending remains elevated: Research and development expense increased to $35.1 million in Q2 2026 from $29.5 million in Q1 and $22.2 million in Q2 2025. This spending could support future pipeline development, but it is also the primary driver of ongoing losses.
  • Investment income is helping offset operating losses: Interest and investment income contributed $4.8 million in Q2 2026, but this was down from $5.0 million in Q1 and $5.6 million in Q3 2025. The company therefore remains exposed to changes in interest rates and investment balances.
  • Septerna continues to consume cash from operations: Operating cash flow was negative $22.2 million in Q2 2026 and negative $25.6 million in Q1. First-half operating cash burn totaled approximately $47.8 million, higher than the $43.6 million consumed during the first half of 2025.
  • The company remains firmly unprofitable: Q2 2026 net loss was $13.0 million, or $0.29 per diluted share, compared with a $8.6 million loss, or $0.19 per share, in Q1 2026. Retained earnings stood at a deficit of $188.9 million at quarter-end.
  • Cash resources have declined from late 2025 levels: Cash and investments totaled approximately $516.5 million in Q2 2026, down from roughly $556.6 million at September 30, 2025. Continued operating losses could reduce the company’s funding runway if revenue does not continue to grow.

Overall, the financial statements present a company with a stronger commercial revenue base and a well-capitalized balance sheet, but not yet a self-sustaining business. Investors should monitor whether revenue growth continues to outpace research and development spending and whether operating cash burn begins to moderate.

11/16/26 08:11 PM ETAI Generated. May Contain Errors.

Septerna Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Septerna's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Septerna's net income appears to be on a downward trend, with a most recent value of -$48.88 million in 2025, compared with $4.18 million in 2023. The previous period was -$71.80 million in 2024. Check out Septerna's forecast to explore projected trends and price targets.

Septerna's total operating income in 2025 was -$68.30 million, based on the following breakdown:
  • Total Gross Profit: $45.95 million
  • Total Operating Expenses: $114.25 million

Over the last 2 years, Septerna's total revenue changed from $151 thousand in 2023 to $45.95 million in 2025, a change of 30,331.1%.

In the past 8 quarters, Septerna's cash and equivalents has ranged from $71.61 million in Q1 2026 to $319.99 million in Q3 2025, and is currently $167.12 million as of their latest financial filing in Q3 2026.

Septerna had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2023.

Over the last 2 years, Septerna's book value per share changed from -19.90 in 2023 to 8.53 in 2025.



Financial statements for NASDAQ:SEPN last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners